Silvia Luque announced on LinkedIn that she was named head of US marketing at Zealand Pharma. She had been executive director of commercial strategy for Lilly's Zepbound since 2022.
July 17, 2026 07:00 AM EDT
Peer Review
Zealand Pharma gets its US marketing leader from Lilly; Bexorg turns to Biohaven for CSO hire
Alex Hoffman
Copy Chief and News Editor
Thomas Lampron formally announced on LinkedIn this week that he is 'thrilled to join the powerhouse team at Revolution Medicines'…
As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. | As…
As its ultra-rare disease med Miplyffa strengthens its foothold in the U.S., Zevra Therapeutics’ CEO believes the launch has the…
Boehringer Ingelheim has brought in Christie Bloomquist as SVP, corporate affairs, US human pharma, and she’ll be president of…
With phase 3 results that have “exceeded” BioMarin’s expectations, according to R&D chief Greg Friberg, M.D., the California…
Welcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan…
